Thrombolytic therapy for pulmonary embolism
Background: Thrombolytic therapy (powerful anticoagulation drugs) is usually reserved for patients with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and reduce the death rate associated with PE.
Đọc thêm![](/images/whatsappp.png)